PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F10BN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $41,482
Award facts
- Contract value 100% obligated
- $41,481.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $41,481.60, was awarded on December 17, 2025, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with an ultimate completion date of December 18, 2025, funded by the Defense Logistics Agency's Medical Supply Chain division. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. The delivery order was awarded on a competitive, non-set-aside basis and will be performed at the vendor's Corporate Office location in Conshohocken, PA.
AmerisourceBergen Drug Corp is a critical federal vendor for medical procurement, particularly serving military and veteran healthcare systems through delivery orders covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements, ranging from small-value transactions to substantial orders exceeding $45,000, with consistent use of firm fixed pricing structures. This contract further strengthens AmerisourceBergen's role within the DLA's Pharmaceutical Prime Vendor Global Program, which is planning multiple regional awards to ensure comprehensive pharmaceutical support across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2D826F10BN?
SPE2D826F10BN was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 17, 2025.
How much is contract SPE2D826F10BN worth?
The government has obligated $41,482 on SPE2D826F10BN.
Is contract SPE2D826F10BN an order under another contract?
Yes. SPE2D826F10BN is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F10BN competed?
The extent of competition for SPE2D826F10BN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award